| Customization: | Available |
|---|---|
| Transport Package: | Carton |
| Specification: | 5mg 10mg |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Levcetirizine hydrochloride tablet |
| Main Ingredients | Levocetirizine hydrochloride |
| Adaptation disease | (1) Allergic rhinitis (seasonal and perennial persistent allergic rhinitis) (2) Chronic idiopathic urticaria |
| Dosage form | Troche |
| Character | This product is white film sheet, white or white after removing the film. |
| Specification | (1)5mg (2)10mg |
| Usage and dosage | For adults and children over 6 years old, take one tablet once daily. Children 2 to 6 years old, one half tablet once a day. |
| Storage | Store in sealed and dry place |
| Origin | China |
| Validity | 24 months |
| Tatoo | 1. Do not use in persons who are allergic to any of the ingredients or to piperazine derivatives. 2. Contraindicated for patients with advanced renal disease whose creatinine clearance rate is <10ml/ min. Contraindicated in patients with specific genetic disorders, including rare galactose intolerance, primary lactase deficiency or glucose-galactose malabsorption. |
| Notice | 1, adverse reactions: this product can make individual patients have headache, drowsiness, dry mouth, fatigue, weakness, abdominal pain and other adverse reactions. 2. Matters needing attention (1) This product is not recommended for children under 6 years of age as currently available film tablets of this product do not allow adjustment of dosage. (2) Although there is no research data at present, the central nervous system may be affected when levositirizine hydrochloride is taken together with alcohol or CNS inhibitors in some sensitive patients. (3) Effects on driving and operating mechanical abilities: Controlled clinical trials have confirmed that levcetirizine does not impair alertness, reaction and driving abilities at recommended doses. Do not overdose if the patient needs to drive, engage in potentially dangerous activities or operate machinery and consider their reaction to the product; Combined use of alcohol or other central nervous system inhibitors may result in reduced alertness and impaired operational ability. (4) For pregnant women and lactating women, levcetirizine has not been shown to have adverse reactions in animal reproductive toxicity studies, and there is no clinical data on its application to pregnant women, so it is not recommended for pregnant women. Levcetirizine is secreted from breast milk and is not recommended for lactating women. (5) Drug overdose symptoms and treatment methods: Symptoms: drowsiness in adults, initial excitement followed by drowsiness in children. Treatment: There is no specific antidote. Symptomatic treatment and supportive treatment are recommended after overdose. Consider gastric lavage if just taken; Hemodialysis was not effective in removing the product. |
){kind=link}